Longitudinal Changes of Brain Functional Connectivity in Migraine
NCT ID: NCT03487978
Last Updated: 2020-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2017-07-24
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resting-state Functional Connectivity Changes During Migraine Treatment
NCT03484871
Hypothalamus Connectivity in Chronic and Episodic Migraine
NCT02328976
Change in Connectivity After mTBI Depending on Cognitive Reserve
NCT05593172
Resting State Functional Connectivity in Cluster Headache
NCT06206772
Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioning and Psychological Variables
NCT07233941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Migraineurs
Patients diagnosed with migraine based on the ICHD-3 beta will undergo 3-tesla resting-state functional MRI.
resting-state functional MRI
1. To ensure inter-ictal fMRI, confirm that the subject has no migraine for at least 48 hours before the procedure.
2. Record the time difference between the date on the day of fMRI and the date of the last headache attack and record whether the headache on the day of fMRI is absent or not.
3. On the third day after MRI, examine whether the subject has headache or not.
Control
Normal controls without headaches will undergo 3-tesla resting-state functional MRI.
resting-state functional MRI
1. To ensure inter-ictal fMRI, confirm that the subject has no migraine for at least 48 hours before the procedure.
2. Record the time difference between the date on the day of fMRI and the date of the last headache attack and record whether the headache on the day of fMRI is absent or not.
3. On the third day after MRI, examine whether the subject has headache or not.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
resting-state functional MRI
1. To ensure inter-ictal fMRI, confirm that the subject has no migraine for at least 48 hours before the procedure.
2. Record the time difference between the date on the day of fMRI and the date of the last headache attack and record whether the headache on the day of fMRI is absent or not.
3. On the third day after MRI, examine whether the subject has headache or not.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. age 18-50 years
2. migraine with or without aura as defined by the third edition of the International Classification of Headache Disorders (ICHD-3 beta)
3. if female, before the onset of menopausal
Controls:
1. age 18-50 years
2. no headache disorder other than Infrequent episodic tension-type headache as defined by the ICHD-3 beta
Exclusion Criteria
2. pregnancy
3. require sedation treatment because of claustrophobia when performing MRI
4. predicted to be unable to write the headache diary due to cognitive decline
5. refuse study procedure
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Foundation of Korea
OTHER
Sungkyunkwan University
OTHER
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chin-Sang Chung
MD, PhD, Professor of neurology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mi Ji Lee, MD
Role: PRINCIPAL_INVESTIGATOR
Samsung Medical Center, Sungkyunkwan University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-03-113
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.